Of note, the relative contribution of primary disease to global tumor burden as a determinant of ethical endpoint was not affected by the whole-body deletion of Ripk3 (p value: 0.1780) or Mlkl (p value: 0.2056) (Fig. 3C). The gene discussed is MLKL; the disease is neoplasm.